Proteus mirabilis strains are human pathogens responsible for urinary tract infections and bacteremias and may be involved in rheumatoid arthritis. Lipopolysaccharide (LPS, bacterial endotoxin), the major component of the cell wall, is one of the virulence factors of Proteus. In the presented studies, we have investigated complement activation by LPSs isolated from P. mirabilis O10, O23, O30, and O43 strains, which differ in the number of negative COO Ð groups on their polysaccharide components. Four P. mirabilis strains studied were sensitive to complement-mediated killing, despite complement binding by their LPSs. The optimal complement binding by LPSs was detected in serum with functional assays for both the classical and alternative pathways.
INTRODUCTION
Bacteria of the genus Proteus are facultative human pathogens responsible for urinary tract infections 1,2 and bacteremias. 3Ð5 It has also been suggested that Proteus surface antigens may play a role in rheumatoid arthritis (RA). 6Ð8 Lipopolysaccharide (LPS) is considered to be an important virulence factor of Proteus. 1, 2 There are different mechanisms for LPS-mediated complement activation. 9 The antibody-independent classical pathway (CP) is mediated only by the lipid A portion of the molecule. 10 Activation of the alternative pathway (AP) requires the polysaccharide moieties of LPS, core oligosaccharide and/or O-antigen polysaccharides. 9, 10 The results of several LPS structureÐfunction studies during the last decade show that O-antigen structure, but not LPS polysaccharide chain length, affected the AP-activating capacity of different LPSs. 9Ð12 We have been studying the structure and serological specificity of R-and O-antigens of P. mirabilis, Proteus vulgaris and Proteus penneri, including those of strains belonging to serogroups described as human pathogens. 13Ð20 All Proteus O-polysaccharides contain N-acetylated hexosamines. Remarkably, 25 of 39 Proteus LPSs studied contain uronic acid residues. 14, 15 The negatively charged lipopolysaccharide and capsular polysaccharides are important barriers against the bactericidal action of the complement system. 9, 21 In this study representative of Proteus genera, smooth P. mirabilis O10, O23, O30, and O43 LPSs were chosen. The O-specific polysaccharide part of LPSs are built up with uronic acids and hexosamines in different linkage modes.
The aims of this study were to investigate: (i) the complement-mediated killing of P. mirabilis O10, O23, O30, and O43 strains, carrying structurally different, negatively charged lipopolysaccharides; (ii) the complement deposition by P. mirabilis O10, O23, O30, and O43 LPSs; and (iii) complement factor C3 fragmentation by Proteus O10, O23, O30, and O43 LPSs. The complement components in serum are not present in equimolar ratios. 21, 22 Therefore, in our experiments, in order to avoid artefacts, we used sera diluted not more than 50%.
MATERIALS AND METHODS
Lipopolysaccharides P. mirabilis O10 (PrK 19/57), O23 (PrK 41/57), O30 (PrK 53/67), O43 (PrK 69/57) laboratory strains came from the Czech National Collection of Type Cultures (Institute of Epidemiology and Microbiology, Prague, Czech Republic). The bacteria were cultivated under aerobic conditions in nutrient broth (BTL Comp. Lodz, Poland). Smooth forms of Proteus LPSs were extracted using the hot phenol-water method as described 23 and purified by DNAse and RNAse (Sigma Chemical Co., St Louis, MO, USA) treatment. 13 The delipidation of LPS was performed using 1% acetic acid at 100¡C until lipid A was precipitated. The insoluble lipid fraction was pelleted by centrifugation (15,000 g, for 60 min). The supernatant was fractionated on a Sephadex G-50 (Pharmacia Fine Chemicals, Uppsala, Sweden) column. The long chain O-specific polysaccharide (F1 fraction) and core oligosaccharide (F2 fraction) were eluted with 0.05 M pyridine acetate buffer, pH 4.5.
Complement
Blood samples obtained from healthy donors by venepuncture were collected into dry vacutainer tubes, allowed to clot for about 1 h at room temperature and then centrifuged at 4¡C. 22, 24 The serum was frozen in liquid nitrogen and stored in 0.2 ml aliquots at Ð70¡C until tested. In some experiments, guinea pig sera (Animal House, Mother and Child Memorial Hospital, Lodz, Poland) were used. In some assays, the human or guinea pig sera were chelated with 10 mM EGTA containing 10 mM MgCl 2 to block activation of the classical complement pathway. To block the alternative pathway of complement activation, serum was incubated for 20 min at 50¡C. Heat-inactivated serum (30 min at 56¡C) was used as control serum with inactive complement.
Complement-mediated bactericidal assay
Proteus strains were grown overnight in Mueller-Hinton broth. When the cultures reached an absorbancy at 640 nm (A 640 ) of 0.6, the bacteria were diluted in PBS from 10 2 to less then 1 cell/well, in V-bottomed microtiter plates (NUNC, Denmark). Reaction mixtures were prepared by combining 25 µl of the diluted bacterial suspension and 75 µl of human test sera that contained an intact or heatinactivated complement system. To control for bacterial dilution, microtiter plates with 25 µl of the diluted bacterial suspension plus 75 µl Mueller-Hinton broth were used. The reaction mixtures were incubated for 16 h at 37¡C with shaking, then bacteria were pelleted (3000 g for 15 min), and bacterial sediments were evaluated on a scale from one to three. The bactericidal activities were calculated by comparing the sediment of bacterial survivors in reaction mixtures containing active serum (intact complement source) to those in mixtures containing heat-inactivated serum (absence of active complement) and the control microplate containing Mueller-Hinton broth. Each assay was repeated at least three times, and representative results are presented.
Complement-dependent hemolytic assay
Binding of complement by LPSs was determined by inhibition of the lysis of sheep erythrocytes, sensitised by antisheep erythrocyte antibodies. 22, 25 Briefly, complement fixation was determined in V-bottomed microtiter plates (NUNC). Serial dilutions of LPS in buffered saline at pH 7.4 (12.5 µl) were incubated for 30 min at 37¡C with 50 µl guinea pig serum (80% final concentration). The mixture of LPS and serum was cooled to 4¡C, followed by dilution sufficient to produce 60Ð80% lysis of erythrocytes. After incubation for 60 min at 37¡C with gentle mixing, 50 µl of the sensitised sheep erythrocytes (0.5%) were added. The non-lysed erythrocytes were pelleted (3000 g for 15 min) and 90 µl of the supernatants were transferred to flat-bottomed microtiter plates (Costar, Cambridge, MA, USA). Absorbancies of the free hemoglobin were measured at 405 nm using a multichannel plate reader (Labsystems Multiscan, Finland). Each sample was run in triplicate, and experiments were repeated at least twice.
Capture ELISA
ELISA measurements of C3 conversion were based on a method described by Holmskov-Nielsen. 26 The assay detects neo-determinants on C3c moieties after C3 conversion. 27 Human serum alone and serum (80% final concentration) plus LPSs were incubated for 15 min at 37¡C, and then the reaction was stopped by dilution of 1/2000 in ice-cold PBS supplemented with 10 mM EDTA and 0.2% Tween. The optimal dilution of 1/2000 was established in pretest experiments. The diluted mixtures of serum and LPS were transferred to plates (flat bottom, high binding; Costar) precoated by a 2 h incubation at 37¡C with rabbit anti-human C3c antibodies (DAKO A/S, Denmark), diluted 1/500 in 0.1 M sodium carbonate buffer, pH 9.6. Precoated plates with diluted mixtures of serum and LPS were incubated for 2 h at 10¡C, and the amounts of captured C3c fragments were then detected by incubation for 30 min at 37¡C with secondary antibodies, i.e. horseradish peroxidase-conjugated rabbit anti-C3c antibodies (DAKO A/S; diluted 1/2000 in PBS, 1% BSA, 0.2% Tween). After each step, the plates were washed 8 times with PBS (Titrek Microplate Washer, M96V, ICN Flow, UK). The enzyme activity remaining in the wells was estimated by adding 0.1 ml OPD (1,2-phenylenediamine dichloride, DAKO A/S) solution. After 10 min at room temperature, the reaction was stopped with 0.1 ml of 0.5 M H 2 SO 4 . The absorbancy at 492 nm was read using a multichannel spectrophotometer (Labsystems Multiscan Plus, Finland). Three to nine replicates per sample were run. As a negative control in each experiment, serum alone or heat-inactivated serum (30 min, 56¡C) was used. All experiments were run at least 3 times, and mean values are presented.
Detection of complement activation by immobilized LPS
96-well plates were coated with LPS diluted to 100 µg/ml in 0.05 M carbonate buffer, pH 9.6 for 18 h at 4¡C. After washing (4 times) with PBS, plates were incubated with anti-P. mirabilis O10 and O24 (control) antibodies (1:100 diluted in PBS). To immobilized O10 and antibodies, human serum diluted from 25% to 3% in veronal buffer (VB) or VB plus 10 mM EGTA was added for 30 min at 37¡C. After washing with PBS (4 times), the deposition of C3 protein was detected with HRP-conjugated rabbit antihuman C3c, diluted 1/5000 in PBS containing 1% BSA and 0.02% Tween. Non-coated plate wells incubated with serum alone were negative controls. The colour reaction was developed, and measurements were made as described above. Each sample was analysed in triplicate. The experiment was performed 3 times. Results are presented as mean values ± standard error.
Sodium dodecyl sulfateÐpolyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting
Serum (75% final concentration) alone or serum plus 1 µg/ml LPS was incubated for 1 h at 37¡C; the mixture was then incubated at 37¡C for 2 h with disintegration buffer. SDS-PAGE was performed according to the procedure described previously. 13 Briefly, samples were loaded onto gels (3.5% stacking gel and 12.5% running gel). The gels were stained with silver or electroblotted onto nitrocellulose. In some experiments, the filter was incubated 60 min at 37¡C with human normal or heatinactivated serum (75% final dilution). In the dot blot assay, 1000 ng of LPS in PBS was dotted onto pieces of nitrocellulose paper, air dried, and then blocked with a 10% skimmed milk solution. The immobilized LPS was then incubated with human sera as described above.
The secondary antibodies used for immunoblotting were the same types of antibodies as those used for the ELISA (HRP-conjugated rabbit anti-human C3c antibodies). The colour development reagent contained 4chloro-1-naphthol (BioRad) and H 2 O 2 as substrates.
Crossed immunoelectrophoresis
C3 conversion products were detected with crossed immunoelectrophoresis, as previously described. 28 The human complement proteins, activated by LPSs for 15 min at 37¡C, were separated by agarose (0.6%, Seakem, FMC, USA, in 0.075 M veronal buffer supplemented with 2 mM EDTA) gel electrophoresis for 1 h (1 V/cm) at about 8¡C. The electrophoresis-separated proteins were transferred to a second agarose gel containing 0.6% rabbit anti-human C3c antibodies (DAKO A/S). The second electrophoresis was performed for 3 h, and the gels were pressed, fixed and the precipitates stained with Coomassie brilliant blue (0.5%). The C3 conversion was quantified by projection of immunoplates onto to a planimeter.
Reagents
EDTA, EGTA, and inulin were purchased from Sigma Chemical Co. (St Louis, MO, USA).
Statistics
The statistical data analyses (P values) were performed by non-parametric Smirnov-Kolmogorov methods as well as by a paired StudentÕs t-test. 29, 30 
RESULTS

Complement-mediated bactericidal activities of human sera
The O-polysaccharides component of LPSs, isolated from P. mirabilis strains used in the study, contain similar components Ð hexosamines and uronic acid residues linked in different modes. The structure of the Proteus O-polysaccharide LPSs are presented in Table 1 . The details of structural studies by Knirel and co-workers based on nuclear magnetic resonance (NMR) methods were described previously. 2,14Ð20,31Ð34
The serum resistance of P. mirabilis O10, O23, O30, and O43 strains were tested using assays resembling in vivo conditions. The bacteria were diluted such that single Proteus cells were exposed to a 75% final concentration of human serum (Table 2 ). This is the condition when single Proteus cells enter blood vessels. All four P. mirabilis strains were serum sensitive, and, in native serum, no surviving bacterial cells were found. The heat-inactivated serum also reduced bacterial growth in comparison to the cultures growing in Mueller-Hinton broth. These results indicate that, in addition to complement-mediated lysis, other serum components, i.e. lysozymes, may inhibit P. mirabilis growth. The results of bactericidal assays showed that the cell surface exposed, negatively charged O-polysaccharides of P. mirabilis O10, O23, O30, and O43 strains did not prevent complement-mediated lysis.
Complement activation by Proteus LPSs, determined by hemolytic complement assay
The inhibition of immunohemolysis by negatively charged, smooth forms of P. mirabilis O10, O23, O30, and O43 LPSs was used to assess their complement fixation 
Abbreviations: L-Alt, altruronic acid; GalA, galacturonic acid; GlcA, glucuronic acid; GalNAc, 2-acetamido-2-deoxygalactose; GlcNAc, 2-acetamido-2-deoxy-glucose; p.-pyranose form of hexose. activities (Fig. 1A) . Pre-incubation with guinea pig serum (80% final concentration) with P. mirabilis LPSs reduced immunohemolysis in an LPS-dose-dependent fashion. The results of immunohemolysis inhibition indicated the diverse complement binding abilities of the four Proteus LPSs studied. The most potent inhibitor was O30 LPS. The O23 LPS showed the lowest complement binding activity.
In sera with inactivated alternative (classical pathway active) or classical (alternative pathway active) pathways, the complement activation by LPSs studied were significantly reduced ( Fig 1B) . These results indicate that both complement pathways, classical and alternative, are required for optimal complement-binding by P. mirabilis O10, O23, O30, and O43 LPSs. As in native serum, the most potent complement binding abilities were demonstrated by P.
mirabilis O30 LPS in serum with an active classical pathway and inactive alternative pathway. The complement binding by P. mirabilis O10, O23, O30, and O43 LPSs were significantly enhanced in the presence of rabbit anti-O antibodies (Fig. 2) . The antibody dilution-dependent enhancement of complement binding by LPSs was observed in both the classical and alternative complement pathways of sera.
Capture ELISA estimation of C3c neo-determinants induced by P. mirabilis LPSs
The complement activation by Proteus LPSs may involve multistep events. In the next experiments, we correlated Complement activation by Proteus lipopolysaccharides 227 In each experiment, the following controls were used: heat-inactivated serum (after incubation for 30 min at 56¡C), serum alone, and LPS alone. Before each experiment, the dilution of complement that hemolyzed 60Ð80% of sensitised rabbit erythrocytes was established.
B
A the inhibition of complement-mediated immunohemolysis by Proteus LPSs with their ability to fragment complement factor C3. The third component of complement, C3, occupies a pivotal position at the junction of the classical, alternative and lectin pathways of complement activation. 35 Quantification of C3 fragments, such as C3c, is useful for assessment of C3 activation. 26 Therefore, the fragmentation of complement factor C3 by the four, negatively charged Proteus LPSs was tested by capture ELISA. A representative experiment of C3 breakdown by smooth Proteus LPSs is presented in Table 3 . The anti-C3c antibodies reacted with epitopes present in serum without LPSs. However, the mixture of LPS and serum induced more C3c neo-epitopes than serum alone. This effect was not observed when a mixture of heat-inactivated serum plus LPSs was used (data not shown). The results shown in Table 3 were repeated in 10 independent experiments; the statistical analysis is presented in Table 3 . All four LPSs studied significantly induced C3c neo-determinants greater than the control serum alone (P <0.0001). This was shown by the non-parametric Smirnov-Kologomorov test, as well as by parametric StudentÕs t-test. These results indicated that Proteus LPSs fragmented C3, and fluid phase C3c neo-epitopes reacted with anti C3c antibodies. Increases in C3c neo-epitopes accompanied by C3 fragmentation has also been shown by others. 26, 27 A comparison between the amount of C3c neo-epitopes induced by O23 and P. mirabilis O10, O30, and O43 LPSs demonstrated that O23 LPS induced a statistically lower amount than the other LPSs (P = 0.001). The results of the capture ELISA correlated with the lower 228 Kaca, Literacka, Sjšholm, Weintraub Fig. 2 . Effect of rabbit anti-O10, -O23, -O30, and -O43 P. mirabilis antibodies and lipopolysaccharides on guinea pig complement-mediated lysis of sheep erythrocytes. The serially diluted rabbit anti-O antibodies (rabbit sera, in which complement was inactivated, 56¡C, 30 min) were bound to homologous LPSs for 30 min at 37¡C and then cooled to 4¡C. The LPS concentrations were those required for 25% of complement binding (see Fig. 1 ): 2, 4, 8, and 32 µg/ml of O30, O10, O43, and O23, respectively. The guinea pig serum (80% final dilution) was then added for 30 min at 37¡C, and residual complement activity was determined as described in the caption to Figure 1 . As a negative control, serially diluted anti-O antibodies without LPS were used. ability of O23 LPS to bind complement as tested by immunohemolysis (Fig. 1A) .
The next experiments were performed to determine whether the fragmentation of C3 is LPS-dose and time dependent. P. mirabilis O10 was chosen as representative of the four negatively charged Proteus LPSs studied. The dose of P. mirabilis O10 LPS that was sufficient to induce C3 fragmentation above control serum alone was 8.3 µg/ml (Fig 3) . This is in the range of LPSs needed for C3 breakdown detected by crossed-immunoelectrophoresis (see below, Fig. 7) .
To identify the components of LPS responsible for C3c generation, native LPS O10 was hydrolysed, and the lipid A as well as the O-specific polysaccharide (F1O10) were isolated. The lipid-free fraction containing the O-polysaccharides of O10 LPS (F1O10), lipid A, and the native O10 LPS molecule were examined (Fig. 4) . Incubation for 15 min at 37¡C with the native P. mirabilis O10 LPS resulted in an increase in C3c of up to 62% above control serum alone. The lipid A O10 and O-specific fraction F1O10 induced only 5% and 11%, respectively, more C3c neoepitopes than serum alone. This suggested that the complete molecule of P. mirabilis O10 LPS is required for efficient generation of C3c. The next set of experiments were carried out to determine whether C3c neo-epitopes are generated by the immobilized form of P. mirabilis Complement activation by Proteus lipopolysaccharides 229 Fig. 3 . C3 conversion by different doses of P. mirabilis O10 LPS. 10 µl of LPS (from 83 to 0.083 µg/ml) in PBS was incubated with 40 µl serum (80% final concentration) for 15 min at 37¡C. The reaction was stopped when the mixture of LPS and serum was diluted 1:2000 in ice-cold PBS, 10 mM EDTA, and 0.02% Tween (pH 7.3). Aliquots (50 µl) were transferred to a microtiter plate coated with polyclonal anti-C3c antibodies. The amount of fixed C3c neoepitopes was then determined with C3c-HRP conjugated antibodies. The results are presented as differences of absorbances (492 nm) between LPS, serum mixtures and serum alone The amounts of generated C3c were determined as described in Materials and Methods. Samples were run in four replicates, and mean values are presented. Fig. 4 . Generation of C3c neo-epitopes in serum incubated with native P. mirabilis O10, its lipid A and O-specific polysaccharide (FIO10). C3c neoepitopes in serum plus activators (25 µg/ml) were detected by capture ELISA (with anti-C3c antibodies, see Fig. 3 ) and expressed as percentage of increase (serum alone = 0%) after 10 min incubation at 37¡C. Complement activators were diluted in PBS, and the final serum concentration was 50%. O10 LPS after interaction with rabbit anti-O antibodies (Fig. 5) . The anti-P. mirabilis O10 rabbit antibodies potentiated C3 fragmentation approximately 3 times more than O10 LPS alone. This was observed with native serum (VB) and with alternative pathway active serum (EGTA) only. The hyperimmune rabbit anti-P. mirabilis O24 serum that was used as a negative serum control did not enhance the C3 fragmentation by O10 LPS. The role of homologous anti-O10 antibodies in enhancement of C3 fragmentation by O10 LPS is in agreement with their abilities to potentiate complement binding as tested by immunohemolysis methods (Fig. 3 ).
Complement activation by P. mirabilis O10 lipopolysaccharide, tested by crossed-immunoelectrophoresis
To confirm the C3 fragmentation by P. mirabilis O10 LPS that was detected by capture ELISA, another method, crossed-immunoelectrophoresis, was used. The anti-C3c antibodies were not specific for C3c neo-epitopes only but precipitated the native C3 as well ( Fig. 6, panel 1) . This was also observed in capture ELISA ( Table 3 ). The smooth P. mirabilis O10 LPS fragmented C3 into two, faster migrating, lower molecular mass fragments, which reacted with anti-C3c antibodies (Fig. 6 ). In the course of the incu-230 Kaca, Literacka, Sjšholm, Weintraub Fig. 5 . The influence of rabbit anti-O10 serum on C3c exposure on immobilized P. mirabilis O10 LPS. To the immobilized P. mirabilis O10 LPS, 1:100 diluted rabbit anti-O P. mirabilis O10 or anti-O P. mirabilis O24 (control) sera were added and incubated for 120 min at 37¡C. After washing with PBS, serial dilutions (in VB or with 10 mM EGTA) of human serum were incubated for 30 min, at 37¡C. After washing, the remaining C3c neo-epitopes were detected with anti-C3c HRP-conjugated antibodies. Fig. 6 . Time dependence of C3 fragmentation in normal human serum treated with P. mirabilis O10 LPS. Crossed immunoelectrophoresis was performed using anti-C3c antibodies. 1, 2, 3, and 4: control serum alone at 37¡C, incubated for 0, 5, 15, 60 min, respectively. 5, 6, 7, and 8: serum with 400 µg/ml P. mirabilis O10 LPS at 37¡C, incubated for 0, 5, 15, 60 min, respectively. Anode is to the left. bation, the formation of fragments containing C3c epitopes was accompanied by a parallel decrease of native C3 (Fig.  6, compare panels 5 and 8 ). The C3 conversion was LPSdose dependent. The O10 LPS at a dose of 4 µg/ml was sufficient to induce the C3 fragmentation ( Fig. 7, panel 4) .
The human C3 fragmentation by O10 LPS at different times is presented in Table 4 . Only 5 min of incubation at 37¡C of human serum with P. mirabilis O10 LPS was needed to induce fragmentation of native C3; 35.9% of native C3 was converted by O10 LPS, in comparison to 5.8% C3c in serum alone. After 60 min of incubation, 54.7% of C3 was broken down in the mixture of serum plus O10 LPS, versus only 8.8% in serum alone ( Table 4 ).
The crossed immunoelectrophoresis experiments as well as the capture ELISA showed that negatively charged P. mirabilis O10 LPSs break down the C3 molecule in a time-and dose-dependent fashion to lower molecular mass fragments that can be detected by anti-C3c antibodies.
Human C3 fragmentation by P. mirabilis O10, O23, O30, and O43 LPSs detected by SDS-PAGE and immunoblotting
The dot-blot experiments showed the deposition of C3c on P. mirabilis O10, O23, O30, and O43 LPSs (Fig. 8 ).
In the control (heat-inactivated serum), only the immobilized O30 LPS bound C3 fragments, expressing C3c neo-epitopes (Fig. 8B) .
The four LPSs studied were separated by SDS-PAGE electrophoresis and transferred to nitrocellulose. Electrophoresed LPSs were then incubated with native and heatinactivated serum. None of the LPSs bound C3, nor did they enhance exposure of C3c neo-epitopes. Pre-incubation with sera did not influence the binding of rabbit anti O30-antibodies to homologous P. mirabilis O30 LPS (data not shown). The failure of C3 deposition by electrophoresed P. O10 LPS, (4, 40, or 400 µg/ml) was incubated with serum for 15 min at 37¡C; in the time-dependence experiments, 40 µg/ml of O10 LPS was used. 100% was the total area of the precipitates (C3 plus C3c). The percentage indicates the fraction of native C3c converted to C3c: NT, not tested. mirabilis O10, O23, O30, and O43 LPSs suggested that disintegrated LPSs are less effective complement activators. It is also possible that the amount of electroblotted LPSs were not sufficient to induce exposure of C3c neoepitopes. This is contrary to native LPSs, immobilized on microtiter plates (see Fig. 5 ) or on nitrocellulose in the dot-blot assay (Fig. 8A) . The next experiment was performed to detect C3 fragmentation induced by the presence of LPSs (Fig. 9 ). The proteins from sera incubated (1 h at 37¡C) with P. mirabilis O30 LPS were transferred to nitrocellulose and detected with polyclonal, rabbit anti-human C3c HRP antibodies. Two slower migrating bands, which reacted with anti-C3c antibodies, appeared after incubation of O30 LPS in native serum (Fig. 9B ). The bands probably represent native C3 and C3bi/C3c. The presence of LPS totally converted native C3 to faster migrating, lower molecular weight bands most probably representing C3d fragments. The C3d fragments that carry the C3c neo-epitopes were detected by anti-C3c antibodies (Fig. 9C) . The results of immunoblotting confirmed the data from the capture ELISA and crossed-immunoelectrophoresis. It is likely that anti-C3c antibodies recognized and reacted with native C3, and the incubation with Proteus LPSs induced C3 fragmentation to the faster migrating, lower molecular mass components that carry the C3c neo-epitopes.
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In conclusion, the P. mirabilis O10, O23, O30, and O43 strains were killed by complement-mediated lysis. The surface-exposed negatively charged LPSs did not inhibit the bactericidal activities of human serum. The results of capture ELISA, crossed-immunoelectrophoresis and inhibition complement-mediated immunohemolysis demonstrated that the negatively charged P. mirabilis O10, O23, O30, and O43 LPSs bind complement and fragment C3 in solution as well as in immobilized form. The complement binding and C3 fragmentation was LPS-dose and time dependent. The anti-complementary abilities of P. mirabilis O10, O23, O30, and O43 LPSs were enhanced by anti-O-antibodies.
DISCUSSION
In the present study, we compared complement activation by four negatively charged, smooth form P. mirabilis O10, O23, O30, and O43 LPSs. The O-polysaccharides of the LPSs differed in the number and position of COO Ð groups. 2, 14, 15 We have shown that smooth P. mirabilis LPSs in 80% human serum increased C3 fragmentation in solution as did immobilized LPSs. With one of the LPSs (O10) used as a model, we have shown that the C3 conversion was O10 LPS-dose and time-dependent and that a complete molecule of O10 LPS is needed for maximal C3 fragmentation. It should be stressed that all the studied smooth Proteus LPSs possessed the ability to break down C3, but the amount of C3c neo-epitopes generated differed depending on the LPS. One can speculate that the basic level of C3 fragmentation by Proteus LPSs that differ in their O-polysaccharide structures is caused by the conserved, common part of Proteus LPSs Ð lipid A. However, the amount of C3 conversion depends on the peculiar structure of P. mirabilis O-polysaccharides. Indeed, we have observed a correlation between reduced complement binding by P. mirabilis O23 LPS (tested by immunohemolysis) and its lesser C3 fragmentation abilities, in comparison to the three other LPSs studied. The most active complement binding abilities were shown by O30 LPS. It differs from the other three Proteus LPSs by the presence of only one residue of uronic acid per one O-specific repeating unit. This is in contrast to the Ospecific polysaccharides from O10, O23, and O43 LPSs that contain two uronic acid residues per repeating unit (see Table 1 ). Perhaps the O-polysaccharide chains of O30 LPS are arranged favorably for C3 binding. In addition, only the O30 LPS in dot-blot analysis bound the C3 from heat-inactivated serum. The specificity and mechanism of that reaction remains to be studied.
The homologous anti-O-antibodies augmented complement binding by the four P. mirabilis LPSs studied. This was observed in native serum as well as in the active classical or alternative complement pathways of sera. The enhancement effect of anti-O antibodies in the classical pathway active serum is probably the result of the reaction of C1q with the Fc fragment of antibodies that bind to long O-chains of polysaccharide of LPS. 9 Augmentation of LPSs complement binding by O-antibodies in serum with the classical pathway inactivated was not expected. As was shown, a single LPS molecule may contain at least three targets for complement fixation, i.e lipid A/Kdo, core oligosaccharide, and O-polysaccharide regions. 10 The antibodies that bound to LPS may change the exposure and surface arrangements of LPS and facilitate the deposition of complement on the LPS structure. It may also have shifted one dominant pathway of complement activation by LPS to another one. Because all three Proteus LPSs studied contain the hexosamines residues, the lectin pathway of complement activation may be an important factor in complement binding kinetics.
The complement binding by Proteus LPSs and C3 fragmentation may depend on the dominant pathway of complement activation, which remains to be studied. The kinetics of C3 conversion by P. mirabilis LPSs may play an important role in the complement-mediated lysis of these bacteria, as was shown with Neisseria gonorrheae. 37 It is important to stress that the surface, negatively charged P. mirabilis strains are sensitive to complementmediated lysis. The complement deposition onto LPSs and C3 fragmentation may be one of the factors that generate the bactericidal activities of human serum against P. mirabilis O10, O23, O30, and O43 strains. The importance of complement activation in the virulence of these bacteria is confirmed by the serum-resistance of 71% of clinical Proteus isolates. 38 Complement activation is one of the important factors in rheumatic diseases. 39, 40 The Proteus surface antigens may play a role in these autoimmune diseases. 6Ð8,41 Our findings that multiple Proteus LPSs bind complement and produce C3 fragmentation may indicate the role of LPS in the inflammation processes of rheumatoid arthritis.
Another condition associated with activation of the complement system by endotoxin is the septic shock syndrome. Complement activation in septic baboons supports the hypothesis that endotoxin may activate complement to a degree which brings the regulatory mechanisms out of control. 42 The C3 fragmentation, produced within a few minutes by series of Proteus endotoxins, may contribute to the release of the highly biologically potent C3a and C3b anaphylatoxins. This phenomenon, relatively nonspecific C3 fragmentation by negatively charged LPSs, may play a role in the inflammatory processes of endotoxic shock, as well as in rheumatoid diseases.
